Muriel Le Romancer

22PUBLICATIONS
36CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Microelectromechanical systems (MEMS)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Mar 09, 2026
Targeting PRMTs Creates Vulnerability of DNA Double-Stand Break Repair Pathways, and Potentiates Chemotherapy Efficacy in TNBC.

Charlène Thiebaut, Sébastien Martinez, Ludivine Pruvost

|Dec 30, 2025
Targeting the JAK/STAT Signaling Pathway in Breast Cancer: Leaps and Hurdles.

Simon Aho, Clio Coste, Luiza Purcari

|Aug 29, 2024
Role of PRMT1 and PRMT5 in Breast Cancer.

Sébastien Martinez, Stéphanie Sentis, Coralie Poulard

|Aug 03, 2023
PRMT5 triggers glucocorticoid-induced cell migration in triple-negative breast cancer.

Lara Malik Noureddine, Julien Ablain, Ausra Surmieliova-Garnès

|Jul 17, 2023
Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα+ breast cancer.

Coralie Poulard, Thuy Ha Pham, Youenn Drouet

|Mar 15, 2023
A hotspot for posttranslational modifications on the androgen receptor dimer interface drives pathology and anti-androgen resistance.

Andrea Alegre-Martí, Alba Jiménez-Panizo, Adrián Martínez-Tébar

Pageof 4

Frequent Collaborators

3 joint publications

Chang Xian Zhang

3 joint publications

Olivier Trédan

3 joint publications

Coralie Poulard

2 joint publications

Loay Kassem